These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22260386)

  • 41. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
    Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunohistochemical profile of renal cell tumours].
    Gutiérrez Olivares VM; González Torres LM; Hunter Cuartas G; Niebles De la Hoz MC
    Rev Esp Patol; 2019; 52(4):214-221. PubMed ID: 31530404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
    Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
    Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
    Mentrikoski MJ; Wendroth SM; Wick MR
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overlapping Immunohistochemical Features of Adenocarcinoma of the Nonpigmented Ciliary Body Epithelium and Renal Cell Carcinoma.
    Hanbazazh M; Barrantes PC; DeVience E; Rana BA; Jadhav N; Gyure K; Grossniklaus HE; Thuro BA; Henneberry J; Milman T; Eagle RC; Shields CL; Shields JA; Dryja TP
    Am J Ophthalmol; 2021 Jun; 226():191-200. PubMed ID: 33529584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
    Kobayashi N; Matsuzaki O; Shirai S; Aoki I; Yao M; Nagashima Y
    Hum Pathol; 2008 Sep; 39(9):1350-9. PubMed ID: 18602672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
    Yu W; Wang Y; Jiang Y; Zhang W; Li Y
    BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of morphologically unclassified renal cell carcinoma with electron microscopy and novel renal markers: implications for tumor reclassification.
    Talento R; Hewan-Lowe K; Yin M
    Ultrastruct Pathol; 2013 Feb; 37(1):70-6. PubMed ID: 23383617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma.
    Cox R; Vang R; Epstein JI
    Am J Surg Pathol; 2014 May; 38(5):713-8. PubMed ID: 24441657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
    Olgac S; Hutchinson B; Tickoo SK; Reuter VE
    Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
    Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
    Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
    Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
    Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytomorphology of clear cell papillary renal cell carcinoma.
    Lin X
    Cancer Cytopathol; 2017 Jan; 125(1):48-54. PubMed ID: 27636377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors.
    Skinnider BF; Folpe AL; Hennigar RA; Lim SD; Cohen C; Tamboli P; Young A; de Peralta-Venturina M; Amin MB
    Am J Surg Pathol; 2005 Jun; 29(6):747-54. PubMed ID: 15897741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
    Downes MR; Torlakovic EE; Aldaoud N; Zlotta AR; Evans AJ; van der Kwast TH
    J Clin Pathol; 2013 Sep; 66(9):779-86. PubMed ID: 23775437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study.
    Tong GX; Yu WM; Beaubier NT; Weeden EM; Hamele-Bena D; Mansukhani MM; O'Toole KM
    Mod Pathol; 2009 Sep; 22(9):1218-27. PubMed ID: 19525927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
    Seo AN; Yoon G; Ro JY
    Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.